Angiotensin I (human, mouse, rat): Atomic Facts for Renin...
Angiotensin I (human, mouse, rat): Atomic Facts for Renin-Angiotensin System Research
Executive Summary: Angiotensin I (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu) is a decapeptide produced by the renin-mediated cleavage of angiotensinogen, functioning as the direct precursor of angiotensin II and lacking intrinsic biological activity [APExBIO Product]. It is widely used in cardiovascular and neuroendocrine research for modeling the renin-angiotensin system, with benchmark experimental protocols including intracerebroventricular injection and screening of antihypertensive drugs [Related Article]. Angiotensin I is stable as a lyophilized solid at -20°C, with high solubility in DMSO, water, and ethanol under defined conditions. Utilization of angiotensin I requires enzymatic conversion to angiotensin II for downstream activity, which activates Gq protein-coupled receptors to initiate vasoconstrictive signaling [Related Article]. Experimental accuracy relies on defined storage, solubilization, and dosing protocols to ensure reproducibility and data reliability.
Biological Rationale
Angiotensin I is a ten-amino-acid peptide (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu) generated from angiotensinogen by renin, a proteolytic enzyme secreted by the kidneys [APExBIO]. The renin-angiotensin system (RAS) regulates fluid balance, blood pressure, and vascular homeostasis in mammals. Angiotensin I itself is inert, but its conversion to angiotensin II by angiotensin-converting enzyme (ACE) is a key regulatory step in vasoconstriction and blood pressure elevation. Defining the roles and processing of angiotensin I is essential for understanding RAS physiology and for developing pharmacological interventions for hypertension and cardiovascular disorders. This article extends the practical scope of previous guides, such as "Reliable Solutions for RAS Research", by providing atomic-level, mechanistic details and experimental benchmarks.
Mechanism of Action of Angiotensin I (human, mouse, rat)
Angiotensin I is generated via the cleavage of angiotensinogen by renin under physiological or experimental conditions. The peptide sequence is H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-OH. Angiotensin I is converted to angiotensin II by ACE through removal of two C-terminal residues (His-Leu). Angiotensin II binds to angiotensin II type 1 (AT1) and type 2 (AT2) G protein-coupled receptors on vascular smooth muscle cells. This triggers Gq protein-mediated activation of phospholipase C, resulting in inositol trisphosphate (IP3) production and calcium release from the endoplasmic reticulum. The net outcome is vasoconstriction and an increase in systemic blood pressure [Mechanistic Review]. The absence of direct bioactivity in angiotensin I allows for precise study of enzymatic conversion and downstream receptor-mediated events.
Evidence & Benchmarks
- Angiotensin I (human, mouse, rat) is chemically stable as a lyophilized solid at -20°C, and should be shipped on blue ice to prevent degradation (APExBIO).
- The peptide is highly soluble at concentrations ≥129.6 mg/mL in DMSO, ≥124.2 mg/mL in water, and ≥9.16 mg/mL in ethanol (APExBIO).
- Angiotensin I is widely used in animal models via intracerebroventricular injection to study fetal blood pressure regulation and activation of hypothalamic arginine vasopressin (AVP) neurons (Scenario Guide).
- Conversion of angiotensin I to angiotensin II by ACE is essential for downstream Gq protein-coupled receptor activation, IP3-dependent calcium signaling, and vasoconstriction (Mechanistic Review).
- Angiotensin I is a gold-standard substrate for screening ACE inhibitors and antihypertensive drugs in biochemical and cell-based assays (Protocol Review).
- Benchmark studies confirm that storage, handling, and solvent conditions critically impact experimental reproducibility (APExBIO).
- APExBIO's Angiotensin I (SKU: A1006) is routinely used in translational research protocols for cardiovascular and neuroendocrine studies (Molecular Insights).
Applications, Limits & Misconceptions
Angiotensin I (human, mouse, rat) is applied in fundamental and translational studies of the renin-angiotensin system, serving as a substrate for ACE, and enabling the screening of inhibitors and the modeling of cardiovascular and neuroendocrine responses. This article updates and clarifies experimental best practices over the review "Biological and Translational Significance" by specifying solvent conditions and workflow integration for APExBIO's high-purity peptide.
- Cardiovascular Disease Mechanisms: Enables modeling of hypertensive responses in animal studies.
- Antihypertensive Drug Screening: Standard substrate for ACE inhibitor assays.
- Neuroendocrine Research: Used to examine hypothalamic activation and AVP neuron signaling.
- Enzymatic Studies: Allows for precise investigation of renin and ACE kinetics.
Common Pitfalls or Misconceptions
- Angiotensin I is not directly vasoconstrictive; biological effects require conversion to angiotensin II.
- Solubility and storage conditions are critical—improper solvent or temperature can lead to peptide degradation or precipitation.
- Species-specific sequence variations can affect enzymatic processing; always verify the source organism.
- Using angiotensin I in the absence of ACE or with ACE inhibitors will block downstream signaling.
- Inter-assay variability can arise from inconsistent handling; rigorous protocol adherence is necessary.
Workflow Integration & Parameters
For experimental use, dissolve angiotensin I in DMSO, water, or ethanol at the recommended concentrations. Filter sterilize if required for cell-based assays. Store aliquots desiccated at -20°C and avoid repeated freeze-thaw cycles. In animal models, intracerebroventricular injection is performed under isoflurane anesthesia, with typical doses ranging from 0.1 to 10 nmol per rat or mouse, adjusted per study design and animal weight. For enzymatic assays, prepare reaction mixtures with defined concentrations of ACE and monitor conversion to angiotensin II via HPLC, mass spectrometry, or immunoassay. The A1006 peptide from APExBIO ensures lot-to-lot consistency and traceability [Product Details]. For stepwise protocols, see the updated guide "Applied Protocols for RAS Research", which this article extends with solubility and storage benchmarks.
Conclusion & Outlook
Angiotensin I (human, mouse, rat) is a foundational and rigorously defined tool for renin-angiotensin system research, enabling reproducible modeling of cardiovascular, neuroendocrine, and pharmacological processes. By adhering to validated storage, handling, and experimental protocols, researchers can optimize data quality and translational impact. The atomic facts and benchmarks presented here clarify scope, highlight pitfalls, and set the groundwork for next-generation studies in hypertension and related disorders. For sourcing, quality assurance, and application notes, refer to APExBIO's Angiotensin I (human, mouse, rat) product page.